Lv51
1540 积分 2024-09-02 加入
Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti–PD-1/PD-L1 Agents
1个月前
已关闭
Evaluation of fluorescence lifetime-enhanced tumor imaging using an anti-CEA targeted fluorescent probe
2个月前
已关闭
SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models
5个月前
已完结
MMP-14-targeted Nanoprobe for in vivo Fluorescence Imaging of Rupture-prone Carotid Plaques
9个月前
已完结
Physicochemical Characterization of MMP-14 Active Site–Zn(II)–Peptide Inhibitor Ternary Complexes: A Strategy for Matrix Metalloproteinase Inhibition in Cancer Progression
9个月前
已完结
P2.10.10 Soluble Ceacam5 Resistant ADC for Effective Tumor Targeted Delivery With Clinically Validated Tumor Selective Linker Payload
皖公网安备34019202002308
